Osiris Therapeutics (OSIR) to Sell Mesenchymal Stem Cell Unit – StreetInsider.com (subscription)
|
Osiris Therapeutics (OSIR) to Sell Mesenchymal Stem Cell Unit
StreetInsider.com (subscription) Osiris Therapeutics, Inc. (Nasdaq: OSIR) and Mesoblast Limited, through its wholly owned subsidiary, Mesoblast International Sárl (“Mesoblast”), entered into a Purchase Agreement, dated October 10, 2013, pursuant to the terms of which the Company sold … |
